Eli Lilly and Company to cut planned €2.3 billion investment in Germany by half, CEO tells newspaper

Eli Lilly and Company will reduce its planned investment in Germany by half, cutting it from €2.3 billion ($2.67 billion), CEO Dave …

Alnylam Pharmaceuticals and Inceptive enter into AI-driven drug discovery partnership worth up to $2 billion

Alnylam Pharmaceuticals said on Wednesday that it has entered into a partnership with AI-driven biotech company Inceptive in a deal valued at …

Travere licenses Everest’s kidney disease drug in a deal valued at up to $1.14 billion

Travere Therapeutics announced on Tuesday that it has entered into a licensing agreement with private biotech firm Everest Medicines to develop and …

Countries strengthen travel restrictions amid rising Ebola concerns

The World Health Organization on Sunday, May 17, declared the Ebola outbreak in the Democratic Republic of the Congo a Public Health …

Apogee secures major $1.3 billion funding agreement from Blackstone for eczema therapy

Apogee Therapeutics announced positive results on Wednesday from a mid-stage clinical trial of its experimental eczema treatment and also secured a financing …

Australia files $1.4 billion lawsuit against 3M over PFAS “forever chemicals” contamination

The Australian government announced on Thursday that it has launched legal action against 3M over contamination linked to firefighting foam supplied by …